
The Bristol office of law firm Shakespeare Martineau has advised on the sale of a long-standing and highly specialised biotech client in a cross-border deal. Tarn-Pure’s technology is used primarily to treat and control water borne pathogens that are harmful to human health, such as legionella, E.coli and pseudomonas. ...